AR008245A1 - Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados - Google Patents

Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados

Info

Publication number
AR008245A1
AR008245A1 ARP970102676A ARP970102676A AR008245A1 AR 008245 A1 AR008245 A1 AR 008245A1 AR P970102676 A ARP970102676 A AR P970102676A AR P970102676 A ARP970102676 A AR P970102676A AR 008245 A1 AR008245 A1 AR 008245A1
Authority
AR
Argentina
Prior art keywords
derivatives
prepare
manufacture
acetic acid
therapeutic agent
Prior art date
Application number
ARP970102676A
Other languages
English (en)
Spanish (es)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AR008245A1 publication Critical patent/AR008245A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP970102676A 1996-06-21 1997-06-18 Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados AR008245A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines

Publications (1)

Publication Number Publication Date
AR008245A1 true AR008245A1 (es) 1999-12-29

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102676A AR008245A1 (es) 1996-06-21 1997-06-18 Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados

Country Status (17)

Country Link
EP (1) EP0912555A1 (cs)
JP (1) JP2000512648A (cs)
KR (1) KR20000022041A (cs)
AP (1) AP9801417A0 (cs)
AR (1) AR008245A1 (cs)
AU (1) AU3261197A (cs)
BR (1) BR9709930A (cs)
CA (1) CA2258753A1 (cs)
CZ (1) CZ424698A3 (cs)
EA (1) EA199801015A1 (cs)
ID (1) ID17052A (cs)
IL (1) IL127464A0 (cs)
IS (1) IS4924A (cs)
NO (1) NO985974L (cs)
PL (1) PL330797A1 (cs)
TR (1) TR199802665T2 (cs)
WO (1) WO1997049699A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
WO2003004488A1 (en) 2001-07-03 2003-01-16 Chiron Corporation Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
TW200401641A (en) 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
TW200505904A (en) * 2003-02-14 2005-02-16 Wyeth Corp Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
CA2648055A1 (en) 2006-04-05 2007-10-18 Wyeth Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
AU2008204583A1 (en) 2007-01-10 2008-07-17 F. Hoffmann-La Roche Ag Sulfonamide derivatives as chymase inhibitors
CN113655155A (zh) * 2021-07-28 2021-11-16 任贤金 一种测定sph3127有关物质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0612313A1 (en) * 1991-11-14 1994-08-31 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
IS4924A (is) 1998-12-15
JP2000512648A (ja) 2000-09-26
AU3261197A (en) 1998-01-14
AP9801417A0 (en) 1998-12-31
NO985974D0 (no) 1998-12-18
CA2258753A1 (en) 1997-12-31
EP0912555A1 (en) 1999-05-06
NO985974L (no) 1999-02-17
IL127464A0 (en) 1999-10-28
EA199801015A1 (ru) 1999-08-26
BR9709930A (pt) 1999-08-10
WO1997049699A1 (en) 1997-12-31
KR20000022041A (ko) 2000-04-25
TR199802665T2 (xx) 1999-03-22
CZ424698A3 (cs) 1999-05-12
ID17052A (id) 1997-12-04
PL330797A1 (en) 1999-06-07

Similar Documents

Publication Publication Date Title
AR024060A1 (es) Nuevos compuestos farmaceuticamente activos
UA41297C2 (uk) Похідні індолу, фармацевтична композиція і спосіб лікування
ES2123654T3 (es) Carbapenems que contienen un grupo fenilo substituido con carboxi, procesos para su preparacion, productos intermedios y uso como antibioticos.
DK1140745T3 (da) Colchinolderivater som vaskulært skadelige midler
ES8604565A1 (es) Un derivado de acido 6-fluor-1, 4-dihidro-4-oxo-7-piperazinil-quinolin sustituido-3-carboxilico
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
MX9204637A (es) Nuevos derivados de pirazina y procedimiento para su preparacion.
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
AR008245A1 (es) Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados
BG101605A (bg) Ентерокинетични бензамиди
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
ES2093246T3 (es) Compuestos de benzazepina terapeuticos.
RU95101437A (ru) Содержащее производные 3-фенилсульфонил-3,7-диазабицикло [3,3,1] нонана лекарственное средство, способ получения производных 3-фенилсульфонил-3,7-диазабицикло-[3,3,1]-нонана
DK527186A (da) Bronchodilaterende farmaceutisk praeparat
ES478984A1 (es) Procedimiento de preparacion de productos del grupo de la e-burnamenina.
GT199900171A (es) Concentrado oral de sertralina.
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
SE9900190D0 (sv) New compounds
DK0541726T3 (da) Vækstfaktorsammensætninger, fremstilling og anvendelse
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
AR005724A1 (es) Derivados de ureido biologicamente activos utiles en el tratamiento de esclerosis multiple